Ertugliflozin: Translating SGLT2 Biology
2026-09-08
Ertugliflozin (PF-04971729) is more than a glucose-lowering tool: its selectivity, clinical outcomes, and translational limitations can guide better renal, cardiovascular, and inflammatory disease assays. This evidence-to-experiment framework helps researchers choose endpoints, controls, and exposure conditions with greater precision.
Forskolin Workflows for cAMP Assays
2026-09-07
Forskolin is a direct adenylate cyclase activator for controlled cAMP stimulation across stem-cell, neuroendocrine, inflammatory, and cardiovascular disease research. This guide combines practical dosing and solubility workflows with assay-design lessons from a recent CFTR trafficking study.
Pterostilbene Mitigates Dermal Fibroblast Senescence
2026-09-05
A 2025 Frontiers in Pharmacology study shows that pterostilbene alleviates human dermal fibroblast senescence by improving mitochondrial quality, respiratory performance, and mitophagy-associated clearance. Its combined cellular and mouse evidence provides a useful framework for studying how mitochondrial maintenance influences collagen loss and dermal aging.
Trelagliptin succinate: Applied Research Workflows
2026-09-05
Trelagliptin succinate, also known as SYR-472 succinate, combines long-acting DPP-4 enzyme inhibition with practical applications in glucose, inflammation, cartilage, adipocyte, and bone assays. This guide translates published AMPK/SOX-9 findings into reproducible workflows, controls, and troubleshooting strategies for diabetes mellitus research.
GS967 for Cardiac Late Sodium Current Studies
2026-09-04
GS967 is a potent cardiac late sodium current inhibitor for connecting Nav1.5 dysregulation with prolonged repolarization, calcium overload, and impaired relaxation. This practical guide outlines concentration selection, cellular and isolated-heart workflows, aging-model applications, and troubleshooting strategies for reproducible arrhythmia prevention research.
Oral Faropenem Sodium and AMR Risk
2026-09-04
The reference article reframes oral faropenem sodium as a stewardship concern, emphasizing that convenience and broad activity may accelerate inappropriate use and cross-resistance with reserved carbapenems. Its literature-based analysis supports more cautious prescribing, laboratory-informed susceptibility assessment, and clearer separation between microbiological potential and proven clinical effectiveness.
Annexin V Workflows for NSCLC Cell-Death Research
2026-09-03
Build a calcium-controlled Annexin V workflow that distinguishes phosphatidylserine externalization from nonspecific membrane damage in cancer models. This guide connects apoptosis assay design with the metabolic findings of a landmark NSCLC study, helping researchers interpret treatment response without mistaking reduced proliferation for cell death.
CRISPR Activation for Splice Variant Diagnostics
2026-09-03
Terkelsen et al. developed an RNA-delivered CRISPR activation assay that induces expression of otherwise inaccessible disease genes in patient-derived skin fibroblasts. By combining dCas9-VPR activation with RT-PCR, next-generation sequencing, and long-read sequencing, the study provides a practical route to functional interpretation of splice-altering variants in their natural genetic context.
Ertugliflozin: Renal Selectivity to Brain Insulin
2026-09-02
Explore how PF-04971729 combines precise renal glucose reabsorption inhibition with emerging effects on brain insulin signaling, tau phosphorylation, and neuroinflammation. This evidence-focused guide translates ertugliflozin research into better assay design and more cautious cross-domain interpretation.
Wild and Cultivated Taihangia rupestris Bioactivity
2026-09-02
A 2026 RSC Advances study integrates UPLC–MS/MS profiling, complementary antioxidant assays, α-glucosidase inhibition, affinity screening, and molecular docking to compare wild and cultivated Taihangia rupestris leaves. Foothill-cultivated plants showed richer flavonoid and phenolic profiles together with stronger antioxidant and enzyme-inhibitory activity, supporting cultivation as a conservation-compatible source for natural product research.
Sulfo-NHS-SS-Biotin for Surface Receptor Biology
2026-09-01
Sulfo-NHS-SS-Biotin enables cleavable surface-protein labeling that can separate receptor abundance from receptor signaling. This article applies its chemistry to assay design for GluN2B-containing NMDAR biology, highlighting controls, interpretation, and reversible protein purification strategies.
ATS-9R for Targeted Adipocyte Gene Silencing
2026-09-01
ATS-9R, also called Adipocyte-targeting sequence-9-arginine, is a non-viral peptide system for delivering nucleic acids to white adipose tissue. Its Prohibitin-mediated uptake and nona-arginine cargo condensation support gene silencing in adipocytes and adipose tissue macrophages in metabolic research models.
Penicillin G Sodium: Workflow and Assay Guide
2026-08-31
Build reproducible antibacterial screens around Penicillin G Sodium by combining concentration-response testing, time-kill measurements, and resistance-aware controls. This guide also translates a cell-based oncology workflow into practical assay-design choices without confusing cancer-cell findings with antibiotic evidence.
H 89 2HCl: Selective PKA Inhibitor Guide
2026-08-30
H 89 2HCl, also called N-(2-(p-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide, is a nanomolar PKA inhibitor used to dissect cAMP/PKA signaling. Its broader kinase activity, solvent limitations, and concentration dependence require appropriate controls.
Ziprasidone HCl: Applied Research Workflows
2026-08-29
Ziprasidone HCl supports a dual research strategy: receptor pharmacology in neuroscience and GOT1-linked metabolic studies in tumor models. This guide converts published benchmarks into practical dosing, permeability, migration, and troubleshooting workflows while separating established evidence from exploratory applications.
460 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page